Study title: Seasonal variation in myopia progression and ocular elongation. Fulk GW, Cyert LA, Parker DA. Optom Vis Sci. 2002 Jan;79(1):46-51. 9. Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Gwiazda J, Marsh-Tootle WL, Hyman L, Hussein M, Norton TT; COMET Study Group. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):314-21. Seasonal variation in myopia progression and ocular elongation. Fulk GW, Cyert LA, Parker DA. Optom Vis Sci. 2002 Jan;79(1):46-51. 9. Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Gwiazda J, Marsh-Tootle WL, Hyman L, Hussein M, Norton TT; COMET Study Group. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):314-21.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Eye Diseases | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: TROPICAMIDE | |||||
| ATC code: S01FA06 | |||||
| Document link: Seasonal variation in myopia progression and ocular elongati.pdf | |||||
| Document date: 2011-11-08 | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |